![Diagnostics Pipeline: Company Receives NIH Grant to Develop Test for Type 1 Diabetes Progression](https://www.g2intelligence.com/wp-content/uploads/2024/07/Aug24.CDI_.DiagnosticsPipeline.Type1DiabetesGrant.RS-iStock-1438179171-1100x800-1-1080x675.jpg)
Diagnostics Pipeline: Company Receives NIH Grant to Develop Test for Type 1 Diabetes Progression
NIH grant awarded to Metabolon is the first phase of what could be a three-year grant, according to a company official
NIH grant awarded to Metabolon is the first phase of what could be a three-year grant, according to a company official
A recent study shows that the proportion of undiagnosed diabetes has dropped over the past three decades, but certain groups are more affected.
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
A new study suggests that this is a viable idea, particularly in the context of diabetes screening in a Latinx community.
Recent study shows that different diabetes screening guidelines are required to produce equal benefits for certain racial groups.